Pharmacotherapeutics in older adults

Journal of Wound, Ostomy and Continence Nursing

Volumn 33, Issue 6, 2006, Pages 630-638

  Hunter, Kathleen F ^a,c   Cyr, Daniel ^b  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b ROYAL ALEXANDRA HOSPITAL   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33751202423     PISSN: 10715754     EISSN: None     Source Type: Journal    
DOI: 10.1097/00152192-200611000-00007     Document Type: Review

References (41)

1. Holford NHG. Pharmacokinetics and pharmacodynamics: rational dosing and the time course of drug action. In: Katzung BG, ed. Basic and Clinical Pharmacology. 8th ed. New York: Lange; 2001:35-50.
2. McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev. 2004;56(2):163-184.
3. Orr WC, Chen CL. Aging and neural control of the GI tract: IV. Clinical and physiological aspects of gastrointestinal motility and aging. Am J Physiol - Gastrointest Liver Physiol. 2002;283(6):G1226-G1231.
4. Kennedy-Malone L, Fletcher KR, Plank LM. Management Guidelines for Gerontological Nurse Practitioners. Philadelphia: F. A. Davis; 2000.
5. Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6-14.
6. Sadowski DC. Drug interactions with antacids. Mechanisms and clinical significance. Drug Safety. 1994;11(6):395-407.
7. Mersebach H, Rasmussen AK, Kirkegaard L, Feldt-Rasmussen U. Intestinal adsorption of levothyroxine by antacids and laxatives: case stories and in vitro experiments. Pharmacol Toxicol. 1999;84(3):107-109.
8. Visser LE, Penning-van Beest FJ, Wilson JH, et al. Over-anticoagulation associated with combined use of lactulose and coumarin anticoagulants. Br J Clin Pharmacol. 2004;57(4):522-524.
9. Katzung BG. Special aspects of geriatric pharmacology. In: Katzung BG, ed. Basic and Clinical Pharmacology. 8th ed. New York: Lange; 2001:1036-1044.
10. Correia MA. Drug biotransformation. In: Katzung BG, ed. Basic and Clinical Pharmacology. 8th ed. New York: Lange; 2001:51-63.
11. Mycek MJ, Harvey RA, Champe PC. Pharmacology. 2nd ed. Philadelphia: Lippincott, Williams & Wilkins; 2000.
12. Veronese ML, Gillen LP, Burke JP, et al. Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice. J Clin Pharmacol. 2003;43(8):831-839.
13. Christensen H, Asberg A, Holmboe AB, Berg KJ. Coadministration of grapefruit juice increases systemic exposure to diltiazem in healthy volunteers. Eur J Clin Pharmacol. 2002;58(8):515-520.
14. Merle L, Laroche ML, Dantoine T, Charmes JP. Predicting and preventing adverse drug reactions in the very old. Drugs Aging. 2005;22(5):375-392.
15. Raz N. Aging of the brain and its impact on cognitive performance: integration of structural and functional findings. In: Craik FIM, Salthouse TA, eds. The Handbook of Aging and Cognition. Mahwah: Lawrence Erlbaum Associates; 2000.
16. Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry. 2001;62(suppl 21):11-14.
17. Vandenberghe R, Tournoy J. Cognitive aging and Alzheimer's disease. Postgrad Med J. 2005;81(956):343-352.
18. McKinney M. Brain cholinergic vulnerability: relevance to behavior and disease. Biochem Pharmacol. 2005;70(8):1115-1124.
19. Broadhurst C, Wilson KCM, Kinirons MT, Wagg A, Dhesi JK. Clinical pharmacology of old age syndrome. Br J Clin Pharmacol. 2003;56:261-272.
20. Resnick NM. Principles of geriatric medicine. Harrison's Online; 2003.
21. Fonda D. Urinary incontinence and bladder dysfunction in older persons. In: Abrams P, Cardozo L, Khoury S, Wein AJ, eds. Incontinence. 2nd ed. Plymouth, UK: Health Publications; 2002.
22. Simonson W, Feinberg JL. Medication-related problems in the elderly: defining the issues and identifying solutions. Drugs Aging. 2005;22(7):559-569.
23. Agostini JV, Leo-Summers LS, Inouye S. Cognitive and other adverse effects of diphenhydramine use in hospitalized older adults. Arch Intern Med. 2001;161:2091-2097.
24. Tromp AM, Pluijm SMF, Smit JH, Deeg DJH, Bouter LM, Lips P. Fall-risk screening test: a prospective study on predictors for falls in community-dwelling elderly. J Clin Epidemiol. 2001;54:837-844.
25. de Rekeneire N, Visser M, Peila R, et al. Is fall just a fall: correlates of falling in healthy older person. The health, aging and body composition study. J Am Geriatr Soc. 2003;51:841-846.
26. Cumming RG, Le Couteur DG. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs. 2003;17(11):825-837.
27. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers Criteria for potentially inappropriate medication use in older adults. Arch Intern Med. 2003;163:2716-2723.
28. Kron M, Loy S, Sturm E, Nikolaus T, Becker C. Risk indicators for falls in institutionalized frail elderly. Am J Epidemiol. 2003;158:645-653.
29. Morrison RS, Magaziner J, Gilbert M, et al. Relationship between pain and opioid analgesics on the development of delirium following hip fracture. J Gerontol Series A - Biol Sci Med Sci. 2003;58(1):76-81.
30. Adunsky A, Levy R, Heim M, Mizrahi E, Arad M. Meperidine analgesia and delirium in aged hip fracture patients. Arch Gerontol Geriatr. 2002;35(3):253-259.
31. Bennett M, Cresswell H. Factors influencing constipation in advanced cancer patients: a prospective study of opioid dose, dantron dose and physical functioning. Palliat Med. 2003;17:418-422.
32. Mullican WS, Lacy JR. Tramadol/acetaminophen combination tablets and codeine/acetaminophen combination capsules for the management of chronic pain: a comparative trial. Clin Ther. 2001;23(9):1429-1445.
33. MICROMEDEX Healthcare Series. Thomson MICROMEDEX. Expires 12/2004. Available at: www.micromedex2; accessed December, 2004.
34. Gambaro G, Perazella MA. Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors. J Intern Med. 2003;253:643-652.
35. Stringer JL. Basic Concepts in Pharmacology. 2nd ed. New York: McGraw-Hill; 2001.
36. Wagg A, Cohen M. Medical therapy for the overactive bladder in the elderly. Age Ageing. 2002;31:241-246.
37. Yu HJ, Wein AJ, Levin RM. Age-related differential susceptibility to calcium channel blocker and low calcium medium in rate detrusor muscle: response to field stimulation. Neurourol Urodyn. 1996;15(5):563-576.
38. Saito M, Kondo A. Effects of verapamil on bladder instability induced by partial outflow obstruction in rat. Int Urol Nephrol. 1998;30(5):543-552.
39. Swift CG. The clinical pharmacology of aging. Br J Clin Pharmacol. 2003;56:249-253.
40. Robbins B, Rausch KJ, Garcia RI, Prestwood KM. Multicultural medication adherence: a cultural study. J Gerontol Nurs. 2004;30(7):25-31.
41. Schlenk EA, Dunbar-Jacob J, Engberg S. Medication non-adherence among older adults: a review of strategies and interventions for improvement. J Gerontol Nurs. 2004;30(7):33-43.